Cargando…

Screening for Microalbuminuria in HIV-Positive Children in Enugu

Background. Human immunodeficiency virus associated nephropathy (HIVAN) is a rapidly progressive chronic renal parenchymal disease that occurs in HIV-infected individuals and manifests commonly as proteinuria, which is preceded by microalbuminuria (MA). This clinical entity is defined as a spot urin...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertilla Uzoma, Ezeonwu, Henrietta Uchenna, Okafor, Anthony Nnaemeka, Ikefuna, Tagbo, Oguonu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399360/
https://www.ncbi.nlm.nih.gov/pubmed/22830018
http://dx.doi.org/10.1155/2012/805834
_version_ 1782238396902539264
author Bertilla Uzoma, Ezeonwu
Henrietta Uchenna, Okafor
Anthony Nnaemeka, Ikefuna
Tagbo, Oguonu
author_facet Bertilla Uzoma, Ezeonwu
Henrietta Uchenna, Okafor
Anthony Nnaemeka, Ikefuna
Tagbo, Oguonu
author_sort Bertilla Uzoma, Ezeonwu
collection PubMed
description Background. Human immunodeficiency virus associated nephropathy (HIVAN) is a rapidly progressive chronic renal parenchymal disease that occurs in HIV-infected individuals and manifests commonly as proteinuria, which is preceded by microalbuminuria (MA). This clinical entity is defined as a spot urine albumin of 20–200 mg/L. Objectives. To determine the prevalence of microalbuminuria in HIV positive children in UNTH, Enugu and compare it with that of HIV-negative children. Methods. A total of 154 HIV positive children aged 18 months to 14 years and 154 HIV-negative children of corresponding attributes were screened for microalbuminuria, using Micral test II strip which has a sensitivity of 90–99%. Results. No child among the groups (HIV positive and negative) had microalbuminuria. Majority (96.0%) of HIV-positive children had nonadvanced HIV disease at the time of the study (P = 0.00). About 77.3% were using HAART (P < 0.0001), the mean CD4 cell count of the subjects was 709.2 ± 443.9 cells/mm(3); while 78.0% had nonsevere immunosuppression (P = 0.00). Furthermore, HIV-positive children with severe immunosuppression were younger and had shorter duration of treatment. Conclusion. Microalbuminuria may not be very common in Nigerian children irrespective of their HIV status.
format Online
Article
Text
id pubmed-3399360
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-33993602012-07-24 Screening for Microalbuminuria in HIV-Positive Children in Enugu Bertilla Uzoma, Ezeonwu Henrietta Uchenna, Okafor Anthony Nnaemeka, Ikefuna Tagbo, Oguonu Int J Nephrol Clinical Study Background. Human immunodeficiency virus associated nephropathy (HIVAN) is a rapidly progressive chronic renal parenchymal disease that occurs in HIV-infected individuals and manifests commonly as proteinuria, which is preceded by microalbuminuria (MA). This clinical entity is defined as a spot urine albumin of 20–200 mg/L. Objectives. To determine the prevalence of microalbuminuria in HIV positive children in UNTH, Enugu and compare it with that of HIV-negative children. Methods. A total of 154 HIV positive children aged 18 months to 14 years and 154 HIV-negative children of corresponding attributes were screened for microalbuminuria, using Micral test II strip which has a sensitivity of 90–99%. Results. No child among the groups (HIV positive and negative) had microalbuminuria. Majority (96.0%) of HIV-positive children had nonadvanced HIV disease at the time of the study (P = 0.00). About 77.3% were using HAART (P < 0.0001), the mean CD4 cell count of the subjects was 709.2 ± 443.9 cells/mm(3); while 78.0% had nonsevere immunosuppression (P = 0.00). Furthermore, HIV-positive children with severe immunosuppression were younger and had shorter duration of treatment. Conclusion. Microalbuminuria may not be very common in Nigerian children irrespective of their HIV status. Hindawi Publishing Corporation 2012-07-08 /pmc/articles/PMC3399360/ /pubmed/22830018 http://dx.doi.org/10.1155/2012/805834 Text en Copyright © 2012 Ezeonwu Bertilla Uzoma et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Bertilla Uzoma, Ezeonwu
Henrietta Uchenna, Okafor
Anthony Nnaemeka, Ikefuna
Tagbo, Oguonu
Screening for Microalbuminuria in HIV-Positive Children in Enugu
title Screening for Microalbuminuria in HIV-Positive Children in Enugu
title_full Screening for Microalbuminuria in HIV-Positive Children in Enugu
title_fullStr Screening for Microalbuminuria in HIV-Positive Children in Enugu
title_full_unstemmed Screening for Microalbuminuria in HIV-Positive Children in Enugu
title_short Screening for Microalbuminuria in HIV-Positive Children in Enugu
title_sort screening for microalbuminuria in hiv-positive children in enugu
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399360/
https://www.ncbi.nlm.nih.gov/pubmed/22830018
http://dx.doi.org/10.1155/2012/805834
work_keys_str_mv AT bertillauzomaezeonwu screeningformicroalbuminuriainhivpositivechildreninenugu
AT henriettauchennaokafor screeningformicroalbuminuriainhivpositivechildreninenugu
AT anthonynnaemekaikefuna screeningformicroalbuminuriainhivpositivechildreninenugu
AT tagbooguonu screeningformicroalbuminuriainhivpositivechildreninenugu